businesspress24.com - Kadmon Corporation to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
 

Kadmon Corporation to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

ID: 1383255

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 09/03/15 -- Kadmon Corporation, LLC today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer of Kadmon, will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015 at 12:05 p.m. ET in New York. Dr. Waksal will provide an overview of Kadmon and its clinical and commercial programs.

A live audio webcast of the presentation will be accessible at . The replay will be available for 90 days following the presentation.

Kadmon Corporation, LLC is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in oncology, autoimmune and fibrotic diseases, metabolic disease and certain monogenic diseases. For more information, visit .

This press release contains forward-looking statements. These forward-looking statements are based on management''s expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.



Ellen Tremaine
Investor Relations
646.490.2989




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Dynavax to Participate in Two Upcoming Investor Conferences
M Pharmaceutical Inc. Advises Shareholders on the Amendment of Terms and Pricing of Warrants
Bereitgestellt von Benutzer: Marketwired
Datum: 03.09.2015 - 07:30 Uhr
Sprache: Deutsch
News-ID 1383255
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 161 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von

Kadmon Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Kadmon Corporation



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 272


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.